Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 36 $ 821
Prepaid and other current assets 756 590
Total current assets 792 1,411
Property and equipment, net 2,366 1,409
Intangible assets, net 1,688 1,598
Right of use asset 797 1,842
Goodwill 652
Deferred debt issuance costs 5,819 150
Other assets 33 180
TOTAL ASSETS 12,147 6,590
Current liabilities:    
Accounts payable 1,822 865
Accrued expenses 408 621
Lease liability - current portion 484 574
Warrant liability 2,721 972
Notes payable at fair value 1,470 1,654
Notes payable 330 8
Total current liabilities 7,235 4,694
Lease liability - non-current portion 355 1,366
Total liabilities 7,590 6,060
Commitments and Contingencies (Note 14)
STOCKHOLDERS’ EQUITY:    
Preferred stock, par value $0.0001; 50,000,000 shares authorized, no shares outstanding
Series A preferred stock, par value $0.0001; 300 shares authorized, 251 shares outstanding as of June 30, 2023 and December 31, 2022; liquidation preference $260 as of June 30, 2023 and December 31, 2022
Series B preferred stock, par value $0.0001; 1,500 shares authorized, 1,443 shares outstanding as of June 30, 2023 and December 31, 2022; liquidation preference $1,492 as of June 30, 2023 and December 31, 2022
Series C preferred stock, par value $0.0001; 600,000 shares authorized, 500,756 shares outstanding as of June 30, 2023 and December 31, 2022; liquidation preference $511 as of June 30, 2023 and December 31, 2022
Series D preferred stock, par value $0.0001; 7,000 shares authorized, 0 shares issued and outstanding as of June 30, 2023 and 1,058 as of December 31, 2022; liquidation preference 0 as of June 30, 2023 and $1,113 as of December 31, 2022
Series E preferred stock, par value $0.0001; 77,000 shares authorized, 21,000 shares committed pending shareholder approval as of June 30, 2023 and no shares outstanding as of December 31, 2022
Series F preferred stock, par value $0.0001; 9,073 shares authorized, 5,251 shares outstanding as of June 30, 2023 and no shares outstanding as of December 31, 2022  
Series F-1 preferred stock, par value $0.0001; 9,052 shares authorized, 3,583 shares outstanding as of June 30, 2023 and no shares outstanding as of December 31, 2022.  
Series F-2 preferred stock, par value $0.0001; 9,052 shares authorized, 1,153 shares outstanding as of June 30, 2023 and no shares outstanding as of December 31, 2022.  
Common stock, par value $0.0001; 800,000,000 shares authorized; 1,067,341 and 337,392 shares outstanding as of June 30, 2023 and December 31, 2022, respectively 6 2
Additional paid-in capital 109,381 88,533
Accumulated deficit (104,830) (88,005)
Total stockholders’ equity 4,557 530
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 12,147 $ 6,590